Loading…
Fenton-like nanoparticles capable of H 2 O 2 self-supply and glutathione consumption for chemodynamic and chemotherapy of cancer
Chemodynamic therapy (CDT) utilizing the Fenton reaction to convert hydrogen peroxide (H O ) into cytotoxic hydroxyl radicals (˙OH) has recently drawn extensive interest in tumor treatment. However, the therapeutic efficiency of CDT often suffers from high concentrations of glutathione (GSH), insuff...
Saved in:
Published in: | Biomaterials science 2024-10, Vol.12 (21), p.5534-5546 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Chemodynamic therapy (CDT) utilizing the Fenton reaction to convert hydrogen peroxide (H
O
) into cytotoxic hydroxyl radicals (˙OH) has recently drawn extensive interest in tumor treatment. However, the therapeutic efficiency of CDT often suffers from high concentrations of glutathione (GSH), insufficient endogenous H
O
and inefficient Fenton activity. Herein, a GSH-depleting and H
O
self-providing nanosystem that can efficiently load copper ions and doxorubicin (DOX) (MSN-Cu
-DOX) to induce enhanced CDT and chemotherapy is proposed. The results show that MSN-Cu
-DOX could release Cu
and DOX under acidic conditions. Particularly, both the released Cu
and Cu
in MSN-Cu
-DOX are available for ˙OH production
a Fenton-like reaction for CDT. Meanwhile, Cu
undergoes a reduction to Cu
by depleting overexpressed GSH, thereby enhancing CDT. Moreover, the released DOX could not only be used for chemotherapy, but also promote the generation of endogenous H
O
to improve the efficiency of a Cu-based Fenton-like reaction. Resultantly, this nanosystem featuring Fenton-like activity, GSH consumption, H
O
self-sufficiency and chemotherapy exhibits a great antitumor effect with a tumor inhibition ratio of 93.05%. Overall, this study provides a promising strategy to enhance CDT for effective tumor therapy. |
---|---|
ISSN: | 2047-4830 2047-4849 |
DOI: | 10.1039/D4BM00930D |